Your browser is no longer supported. Please, upgrade your browser.
VKTX Viking Therapeutics, Inc. daily Stock Chart
VKTX [NASD]
Viking Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.33 Insider Own11.03% Shs Outstand71.81M Perf Week8.31%
Market Cap570.89M Forward P/E- EPS next Y-0.64 Insider Trans0.00% Shs Float64.43M Perf Month-5.36%
Income-23.60M PEG- EPS next Q-0.13 Inst Own59.00% Short Float25.49% Perf Quarter6.28%
Sales- P/S- EPS this Y51.60% Inst Trans-8.72% Short Ratio11.38 Perf Half Y-2.33%
Book/sh3.94 P/B2.02 EPS next Y-64.10% ROA-7.90% Target Price23.70 Perf Year-14.61%
Cash/sh4.01 P/C1.98 EPS next 5Y40.00% ROE-8.10% 52W Range6.15 - 11.03 Perf YTD3.92%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-27.92% Beta2.29
Dividend %- Quick Ratio46.70 Sales past 5Y- Gross Margin- 52W Low29.27% ATR0.40
Employees15 Current Ratio46.70 Sales Q/Q- Oper. Margin- RSI (14)61.30 Volatility4.81% 5.23%
OptionableYes Debt/Eq0.00 EPS Q/Q26.20% Profit Margin- Rel Volume0.92 Prev Close7.90
ShortableYes LT Debt/Eq0.00 EarningsNov 05 BMO Payout- Avg Volume1.44M Price7.95
Recom1.50 SMA207.15% SMA5011.97% SMA2002.05% Volume1,321,007 Change0.63%
Jul-16-19Initiated Oppenheimer Outperform $12
Jun-25-19Initiated Stifel Buy
Mar-29-19Upgrade SVB Leerink Mkt Perform → Outperform $10 → $21
Mar-14-19Reiterated Maxim Group Buy $28 → $20
Feb-22-19Initiated SVB Leerink Mkt Perform
Dec-12-18Initiated B. Riley FBR Buy $16
Nov-19-18Upgrade Raymond James Outperform → Strong Buy
Sep-18-18Reiterated Raymond James Outperform $15 → $43
Sep-18-18Reiterated Maxim Group Buy $14 → $28
Sep-18-18Reiterated H.C. Wainwright Buy $15 → $28
Jul-20-18Initiated SunTrust Buy $14
Jun-28-18Initiated Raymond James Outperform
Jun-01-18Reiterated Laidlaw Buy $10 → $15
May-31-18Reiterated Maxim Group Buy $8 → $14
Mar-26-18Resumed H.C. Wainwright Buy $11
Nov-28-17Reiterated Maxim Group Buy $5 → $8
Nov-21-17Initiated ROTH Capital Buy
Nov-10-17Resumed H.C. Wainwright Buy $7
Jul-17-17Reiterated H.C. Wainwright Buy $5 → $7
Aug-11-16Reiterated Laidlaw Buy $20 → $10
Dec-14-19 09:44PM  Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy? Insider Monkey
Dec-06-19 08:00AM  12 Biotech Stocks Primed For A Short Squeeze Benzinga +5.54%
Nov-21-19 06:50AM  VKTX: Phase2b Trial of VK2809 Underway Zacks Small Cap Research
Nov-19-19 07:05AM  Viking Therapeutics Announces Initiation of Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) PR Newswire -7.45%
Nov-15-19 12:27AM  Edited Transcript of VKTX earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire +5.84%
Nov-09-19 03:53PM  Were Hedge Funds Right About Souring On Viking Therapeutics, Inc. (VKTX)? Insider Monkey
Nov-06-19 08:30AM  VKTX: VK2809 IND Filed; P2b Trial to Initiate in 4Q19 Zacks Small Cap Research -6.01%
Nov-05-19 05:09PM  US Indexes Close Mostly Higher Tuesday GuruFocus.com +19.21%
07:00AM  Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Oct-31-19 07:30AM  Viking Therapeutics to Report Financial Results for Third Quarter 2019 on November 5, 2019 PR Newswire
Sep-25-19 07:30AM  Viking Therapeutics to Present at 2019 Cantor Global Healthcare Conference PR Newswire
Sep-23-19 02:37PM  We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth Simply Wall St.
Sep-09-19 10:00AM  Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics Motley Fool
Aug-28-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Aug-13-19 07:00AM  3 Top Small-Cap Stocks to Buy in August Motley Fool
Aug-11-19 09:15AM  Is Viking Therapeutics a Buy? Motley Fool
Aug-08-19 01:31AM  Edited Transcript of VKTX earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 01:02AM  Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-05-19 04:42PM  Where Will Viking Therapeutics Be in 1 Year? Motley Fool
Aug-02-19 11:30AM  VKTX: Awaiting Feedback from FDA regarding pre-IND submission; Phase 2b trial in NASH expected to initiate 2H19 Zacks Small Cap Research
Aug-01-19 04:05PM  Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Jul-31-19 02:06PM  Options Traders Load Up On VKTX Calls Ahead of Earnings Schaeffer's Investment Research
Jul-25-19 04:05PM  Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019 PR Newswire
Jul-02-19 04:05PM  Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors PR Newswire
Jun-20-19 02:15PM  Heres What Hedge Funds Think About Viking Therapeutics, Inc. (VKTX) Insider Monkey
May-31-19 02:22PM  3 Stocks to Buy and Hold for the Next 50 Years Motley Fool
May-28-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire -8.20%
May-17-19 06:00AM  3 Small-Cap Biotech Stocks You Can Buy Right Now Motley Fool
May-14-19 11:06AM  Have Insiders Been Buying Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares? Simply Wall St. +5.27%
May-09-19 11:06AM  Were Hedge Funds Right About Dumping Viking Therapeutics, Inc. (VKTX) ? Insider Monkey
May-08-19 12:03AM  Edited Transcript of VKTX earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-07-19 06:00AM  3 Top Biotech Stocks to Buy in May Motley Fool -6.51%
May-03-19 03:00PM  VKTX: Pre-IND Meeting with FDA in Summer 2019; Phase 2b NASH Trial to Initiate 2H19 Zacks Small Cap Research
May-02-19 09:10PM  Viking Therapeutics Inc (VKTX) Q1 2019 Earnings Call Transcript Motley Fool
04:05PM  Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Apr-30-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Apr-27-19 08:16AM  2 Reasons Gilead Sciences' NASH Program Could Bounce Back Motley Fool
Apr-25-19 07:30AM  Viking Therapeutics to Report Financial Results for First Quarter 2019 on May 2, 2019 PR Newswire
Apr-12-19 09:45AM  VKTX: VK2809 5 mg Data Presented at EASL Zacks Small Cap Research -6.22%
Apr-11-19 08:52AM  Viking Therapeutics Jumps as New Liver Drug Gets Positive Results Bloomberg
07:02AM  Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress 2019 PR Newswire
Apr-08-19 05:00PM  Why Viking Therapeutics Stock Perked Up in March Motley Fool
Apr-06-19 08:03AM  Here's Why Investors Are Betting Against These 2 Biotech Stocks Motley Fool
Apr-04-19 07:30AM  Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress 2019 PR Newswire
Mar-31-19 09:00AM  3 Top Value Stocks to Buy Right Now Motley Fool
Mar-29-19 04:31PM  Here's What Pushed Viking Therapeutics Higher on Friday Motley Fool +16.80%
10:57AM  The Best Approach to Trading Lyft TheStreet.com
Mar-28-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Mar-22-19 11:39AM  Harry Boxer: 3 biotech stocks with momentum MarketWatch -10.99%
Mar-19-19 01:56AM  Edited Transcript of VKTX earnings conference call or presentation 13-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-14-19 04:20PM  VKTX: Phase 2b Trial for VK2809 to Initiate 2H19 Zacks Small Cap Research -6.42%
02:31AM  Viking Therapeutics (VKTX) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-13-19 04:05PM  Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update PR Newswire
01:15PM  Shareholders Are Raving About How The Viking Therapeutics (NASDAQ:VKTX) Share Price Increased 346% Simply Wall St.
Mar-12-19 06:00AM  3 Stocks That Could Double Your Money Motley Fool
Mar-06-19 07:30AM  Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2018 on March 13, 2019 PR Newswire
Feb-27-19 01:25PM  Is Viking Therapeutics a Buy? Motley Fool
Feb-26-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences and Events PR Newswire
Feb-25-19 07:40AM  Research Report Identifies Wolverine World Wide, Viking Therapeutics, Ampio Pharmaceuticals, ArcelorMittal, Delphi Technologies, and Unit with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-21-19 08:00AM  Healthcare Companies Investors are Watching ACCESSWIRE
Feb-19-19 09:35AM  4 Healthcare Stocks Looking to Start Strong on Tuesday (2/19/19) ACCESSWIRE
Feb-17-19 08:20AM  3 Top Biotech Stocks to Buy in February Motley Fool
Feb-14-19 10:08AM  Should You Buy Viking Therapeutics After Gilead Drug Failure? InvestorPlace
Feb-12-19 04:20PM  Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails Zacks +10.60%
02:57PM  Here's Why Viking Therapeutics Rose as Much as 13.9% Today Motley Fool
02:25PM  These Healthcare Stocks Could Surpass Investor Expectations ACCESSWIRE
11:01AM  Viking Therapeutics Breaks Out After Gilead's Clinical Failure Investopedia
Feb-07-19 09:57PM  Ligand Pharmaceuticals Inc (LGND) Q4 2018 Earnings Conference Call Transcript Motley Fool
Jan-23-19 03:10PM  VKTX: No Cardio Toxicity Concerns for VK2809 Zacks Small Cap Research
Jan-17-19 01:40PM  Viking Therapeutics Stock Regains Ground Investopedia
06:55AM  Citron Says Ligand Has 80% Downside in Explosive Note Investopedia
Jan-16-19 04:18PM  Ligand Crashes To Nearly 2-Year Low After Short-Seller Bashes It Investor's Business Daily -6.10%
03:35PM  Ligand Pharmaceuticals Hit By Bearish Citron Report Benzinga
Jan-13-19 09:00AM  3 Great Stocks Under $10 Motley Fool
Jan-12-19 06:00PM  3 Top Biotech Stocks to Buy in January Motley Fool
Jan-11-19 06:11PM  NASH Space in Focus in 2019 as Firms Look to Diversify Zacks
08:59AM  Here's Why Viking Therapeutics Slid 32.2% in December Motley Fool
Jan-08-19 05:13PM  Here's Why Viking Therapeutics Skyrocketed 88.4% in 2018 Motley Fool
Jan-04-19 08:00AM  Biotech Stocks Set to Start 2019 Off with a Bang ACCESSWIRE +8.84%
Jan-02-19 07:30AM  Viking Therapeutics to Present at Biotech Showcase 2019 PR Newswire +8.76%
Dec-28-18 07:05PM  3 Top Small-Cap Stocks to Buy Right Now Motley Fool
Dec-27-18 03:54PM  Why Viking Therapeutics Sank Today Motley Fool -8.75%
Dec-26-18 10:32AM  3 Biotech Stocks That Are Too Cheap to Ignore Motley Fool +11.73%
08:18AM  Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics Motley Fool
Dec-21-18 12:50PM  Could Viking Therapeutics, Inc.s (NASDAQ:VKTX) Investor Composition Influence The Stock Price? Simply Wall St. -6.19%
Dec-18-18 02:38PM  Edited Transcript of VKTX earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-12-18 01:40AM  Hedge Funds Are Betting On Viking Therapeutics, Inc. (VKTX) Insider Monkey
Dec-10-18 10:28AM  Why Viking Therapeutics Stock Continued to Slide in November Motley Fool
Dec-08-18 03:03PM  Here's Why Madrigal Pharmaceuticals Fell 39.4% in November Motley Fool
Dec-03-18 07:35AM  Factors of Influence in 2018, Key Indicators and Opportunity within The Trade Desk, United Rentals, ServiceMaster Global, Talend S.A, Viking Therapeutics, and SEACOR New Research Emphasizes Economic Growth GlobeNewswire
Nov-27-18 10:00AM  Growth Opportunities in Stocks Coming Off of Bottoms ACCESSWIRE -9.53%
Nov-19-18 02:57PM  Viking Has A More Attractive M&A Valuation Than Madrigal, Raymond James Says In Upgrade Benzinga
Nov-14-18 09:30AM  4 Healthcare Stocks To Watch On Wednesday ACCESSWIRE
08:31AM  Better NASH Stock: Madrigal Pharmaceuticals, Inc. vs. Viking Therapeutics, Inc. Motley Fool
06:50AM  Todays Research Reports on Stocks to Watch: Viking Therapeutics and EyeGate Pharmaceuticals ACCESSWIRE
Nov-13-18 04:36PM  Stocks on the move: higher transportation and raw material cost clash with Home Depot's profitability Yahoo Finance Video
11:54AM  Viking Therapeutics Shows How Quickly This Market Can Turn TheStreet.com
11:00AM  VKTX: Phase 2 Data for VK2809 Presented at AASLD Zacks Small Cap Research
10:45AM  Why Viking Therapeutics Shares Are Finding Renewed Buying Interest Benzinga
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in Phase II clinical trials to treat patients with non-alcoholic fatty liver disease and elevated low-density lipoprotein cholesterol. The company's lead drug candidate also includes VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery. It is also developing VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in preclinical stage for X-linked adrenoleukodystrophy. The company was founded in 2012 and is headquartered in San Diego, California.